Commodore Capital LP Diversified Active

CIK: 0001831942 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $664 (100.0% shares, 0.0% debt)

Holdings (35)

XENE XENON PHARMACEUTICALS INC 9.9%
Value ($000) $65 Shares 1,659,111 Est. Cost $24.84 Unrealized +46.6%
VRDN VIRIDIAN THERAPEUTICS INC 8.9%
Value ($000) $59 Shares 2,020,166 Est. Cost $16.37 Unrealized +40.7%
COGT COGENT BIOSCIENCES INC 7.5%
Value ($000) $50 Shares 4,319,940 Est. Cost $8.05 Unrealized +53.9%
BELLUS HEALTH INC NEW 6.6%
Value ($000) $44 Shares 5,303,557 Est. Cost $7.65 Unrealized
MERUS N V 6.4%
Value ($000) $42 Shares 2,732,567 Est. Cost $24.56 Unrealized
CYMABAY THERAPEUTICS INC 5.4%
Value ($000) $36 Shares 5,738,500 Est. Cost $4.40 Unrealized
ACRS ACLARIS THERAPEUTICS INC 4.5%
Value ($000) $30 Shares 1,880,286 Est. Cost $12.97 Unrealized +24.0%
AKERO THERAPEUTICS INC 4.4%
Value ($000) $29 Shares 537,076 Est. Cost $34.05 Unrealized
NUVL NUVALENT INC 4.1%
Value ($000) $27 Shares 913,621 Est. Cost $27.89 Unrealized 0.0%
CLDX CELLDEX THERAPEUTICS INC NEW 3.3%
Value ($000) $22 Shares 495,823 Est. Cost $30.35 Unrealized +17.6%
IMVT IMMUNOVANT INC 3.1%
Value ($000) $20 Shares 1,150,505 Est. Cost $12.59 Unrealized 0.0%
ARWR ARROWHEAD PHARMACEUTICALS IN 2.8%
Value ($000) $19 Shares 462,111 Est. Cost $37.60 Unrealized -11.9%
CELC CELCUITY INC 2.8%
Value ($000) $19 Shares 1,327,952 Est. Cost $20.81 Unrealized -50.8%
ACLX ARCELLX INC 2.8%
Value ($000) $18 Shares 591,437 Est. Cost $22.94 Unrealized 0.0%
SNDX SYNDAX PHARMACEUTICALS INC 2.6%
Value ($000) $18 Shares 688,445 Est. Cost $22.44 Unrealized +4.0%
DAWN DAY ONE BIOPHARMACEUTICALS I 2.4%
Value ($000) $16 Shares 739,661 Est. Cost $10.33 Unrealized +98.6%
PROMETHEUS BIOSCIENCES INC 2.1%
Value ($000) $14 Shares 127,156 Est. Cost $0.11 Unrealized
ALLAKOS INC 2.1%
Value ($000) $14 Shares 1,643,500 Est. Cost $6.12 Unrealized
KURA KURA ONCOLOGY INC 2.1%
Value ($000) $14 Shares 1,099,407 Est. Cost $14.43 Unrealized +0.7%
FDMT 4D MOLECULAR THERAPEUTICS IN 2.0%
Value ($000) $13 Shares 598,385 Est. Cost $15.45 Unrealized 0.0%
RNAM AVIDITY BIOSCIENCES INC 2.0%
Value ($000) $13 Shares 590,705 Est. Cost $14.91 Unrealized 0.0%
ENTA ENANTA PHARMACEUTICALS INC 1.6%
Value ($000) $10 Shares 223,494 Est. Cost $51.53 Unrealized -11.5%
IMARA INC 1.5%
Value ($000) $10 Shares 2,494,794 Est. Cost $0.00 Unrealized
ALPINE IMMUNE SCIENCES INC 1.5%
Value ($000) $10 Shares 1,325,000 Est. Cost $7.20 Unrealized
89BIO INC 1.5%
Value ($000) $10 Shares 758,244 Est. Cost $0.01 Unrealized
CABA CABALETTA BIO INC 1.4%
Value ($000) $9 Shares 1,010,359 Est. Cost $3.64 Unrealized 0.0%
PCVX VAXCYTE INC 1.3%
Value ($000) $8 Shares 173,481 Est. Cost $39.24 Unrealized 0.0%
KARYOPHARM THERAPEUTICS INC 1.0%
Value ($000) $7 Shares 1,935,609 Est. Cost $7.37 Unrealized
THIRD HARMONIC BIO INC 0.6%
Value ($000) $4 Shares 993,294 Est. Cost $18.97 Unrealized
LRMR LARIMAR THERAPEUTICS INC 0.5%
Value ($000) $3 Shares 750,000 Est. Cost $2.51 Unrealized +36.2%
ABOS ACUMEN PHARMACEUTICALS INC 0.4%
Value ($000) $3 Shares 498,315 Est. Cost $5.74 Unrealized +17.1%
IMUX IMMUNIC INC 0.4%
Value ($000) $3 Shares 1,800,000 Est. Cost $7.12 Unrealized -61.7%
RZLT REZOLUTE INC 0.4%
Value ($000) $3 Shares 1,210,000 Est. Cost $3.32 Unrealized -43.7%
KALV KALVISTA PHARMACEUTICALS INC 0.3%
Value ($000) $2 Shares 312,553 Est. Cost $24.62 Unrealized -78.2%
DBV TECHNOLOGIES S A 0.0%
Value ($000) $0 Shares 92,687 Est. Cost $0.00 Unrealized